Concorde Asset Management’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
FA
IA
II
CW
CFD
LWAM
Concorde Asset Management's IBD Position: Q2 2021 in Review
Concorde Asset Management sold out of Inspire Corporate Bond ETF (IBD) in Q2 2021, closing a stake of 7,999 shares — an estimated $206K sold.
Concorde Asset Management first reported a position in IBD in Q1 2021 and held it in 1 quarter. The position peaked at $206K in Q1 2021. 39 funds tracked by Wall St. Rank hold IBD as of Q2 2021.
- Concorde Asset Management reported no remaining Inspire Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
- Concorde Asset Management sold 7,999 Inspire Corporate Bond ETF shares in Q2 2021, an estimated $206K.
- Concorde Asset Management first reported a position in Inspire Corporate Bond ETF in Q1 2021 and held it in 1 quarter.
- Concorde Asset Management's Inspire Corporate Bond ETF position peaked at $206K in Q1 2021.
- 39 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2021.
Based on Concorde Asset Management's 13F filing for Q2 2021, filed 20 Jul 2021.